Press Releases

September 16th, 2014

New imaging system combines ultra high-frequency ultrasound imaging, quantification and
education in a convenient easy to use all-in-one platform designed for small animal studies
 

 

Toronto, Canada, September 17, 2014 (Booth #510) – FUJIFILM VisualSonics Inc., a world leader in real time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and subsidiary of FUJIFILM SonoSite, Inc., will unveil the world’s first one-touch pre-clinical imaging platform, the Vevo® 3100 on September 17 -20 at the World Molecular Imaging Congress Annual Meeting in Seoul, Korea.

 

“Equipped with new Vevo HD Image Technology, a customizable touchscreen user interface, and onboard learning, the Vevo® 3100 imaging platform allows researchers to experience a new and efficient method of imaging in the pre-clinical research world,” said Naohiro Fujitani, President & CEO, FUJIFILM SonoSite, Inc. “As the undisputed leader in real-time in vivo micro-imaging systems, FUJIFILM VisualSonics once again advances the world of pre-clinical research with the launch of the Vevo® 3100 imaging platform.”

 

July 18th, 2014

Subcommittee on Primary Health and Aging to Explore Stemming More Than 1000 Preventable Deaths Each Day In The US Healthcare System

BOTHELL, WA, July 17, 2014 – FUJIFILM SonoSite Inc., the world leader and specialist in ultrasound performed at the point-of-care, applauds the US Senate Subcommittee on Primary Health and Aging for having a hearing to explore ways to stem the more than 1000 preventable patient deaths a day in the US healthcare system.

"This crisis needs to be addressed at the highest levels sooner rather than later, and we applaud the Senate for taking action," said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM SonoSite. "The fact is that there are many tools and methods to prevent these deaths if adopted broadly across a hospital, including those to significantly reduce a major threat to patient safety –hospital-acquired conditions."

Hospital-acquired conditions (HACs) are complications that a patient may develop during a stay in a hospital or medical facility. To reduce this patient risk, many leading hospitals now mandate that their physicians adopt proven best practices. As an example, the Agency for Healthcare Research and Quality (AHRQ), as well as other medical groups recommend ultrasound-guided central line insertion for safer vascular access, based on overwhelming scientific evidence of its safety benefits.

May 12th, 2014
SonoSite Solutions provides a ready-made, but highly modifiable and scalable, clinical pathway to reduce CVC-insertion complications through the use of point-of-care ultrasound

BOTHELL, WA, May 13, 2014 – FUJIFILM SonoSite Inc., the world leader and pioneering specialist in bedside and point-of-care ultrasound, announced the availability of a new patient-safety program designed to help hospitals reduce complications during CVC insertion. The SonoSite Solution for Safer Central Venous Catheter Insertion includes a guidebook and resource center that provides healthcare professionals with practice guidelines, procedure protocols, key metrics for benchmark success, educational videos and more. Most importantly, a team of Solutions Advisors support the program and help clinicians and administrators at participating institutions navigate through the wealth of available information.

"Central Venous Catheter (CVC) insertion can be risky. Both mechanical complications, such as a pneumothorax, or a Central Line-Associated Blood Stream Infection (CLABSI) can occur during the procedure,” said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM SonoSite, Inc. “An iatrogenic pneumothorax is deemed a high cost and preventable event at many hospitals and healthcare systems and, as of October 2012, the Center for Medicare and Medicaid Services (CMS) will not compensate hospitals for additional costs incurred from this complication."

January 14th, 2014
New open-access VividTrac® device—for “where you need it, when you need it” intubation—
brings video intubation to the forefront of patient care

BOTHELL, WA, January 14, 2014 – FUJIFILM SonoSite, Inc., the world leader and pioneering specialist in bedside and point-of-care ultrasound, today announced a partnership with Vivid Medical Inc. of Palo Alto, CA, to co-promote the VividTrac® Video Intubation Device. VividTrac is the world’s first and only single-use, "open access” video intubation device with a USB interface that connects easily to a variety of display options. By simply plugging the VividTrac device into a compatible system, clinicians will have access to high-resolution video intubation to enhance patient safety and care.

November 8th, 2013

SonoSite's X-Porte™ Ultrasound Kiosk integrates advanced signal processing for high-resolution imaging, 3D animated clinical guides, and a cutting-edge multi-gesture user interface—all first-ever innovations in point-of-care ultrasound

 

BOTHELL, WA – November 8, 2013 – FUJIFILM SonoSite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced it received 510(k) clearance from the FDAi for its newest generation of point-of-care ultrasound: the X-Porte™ Ultrasound Kiosk. Available in a stationary or a detachable use model, SonoSite will begin shipping the X-Porte kiosk in the United States effective immediately. The X-Porte is already available in parts of Europe and Asia-Pacific.

"This is a major accomplishment for SonoSite and a defining moment in the next phase of our innovation strategy," says SonoSite President and CEO Kevin M. Goodwin. "Working side-by-side with hundreds of clinicians from the frontlines of medicine worldwide, we combined their many insights with the most innovative consumer technologies available today. Then, we blended in our own inspiration from key engineers at our company, creating a remarkable new tool built from the ground up."